A Multicenter, US and Canada, Double Blind, Randomized, Placebo-Controlled, Parallel Group Study, for the Efficacy, Tolerability and Safety of Rasagiline Mesylate in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations - TVP-1012/133

Trial Profile

A Multicenter, US and Canada, Double Blind, Randomized, Placebo-Controlled, Parallel Group Study, for the Efficacy, Tolerability and Safety of Rasagiline Mesylate in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations - TVP-1012/133

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Dec 2009

At a glance

  • Drugs Rasagiline (Primary)
  • Indications Parkinson's disease
  • Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
  • Acronyms PRESTO
  • Most Recent Events

    • 27 Dec 2007 Status changed from in progress to completed according to ClinicalTrials.gov.
    • 07 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top